All Stories

  1. Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena)

    Article • European Journal of Preventive Cardiology, October 2019, SAGE Publications

    Dr Marco Gentile

  2. Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome

    Article • Acta Cardiologica, June 2018, Taylor & Francis

    Dr Marco Gentile, Dr Arcangelo Iannuzzi

  3. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia

    Article • European Journal of Preventive Cardiology, March 2017, SAGE Publications

    Dr Marco Gentile

  4. Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia

    Article • Clinical Lipidology, December 2015, Future Medicine

    Dr Marco Gentile

  5. Exercise training reduces high mobility group box-1 protein levels in women with breast cancer: findings from the DIANA-5 study

    Article • Monaldi Archives for Chest Disease, August 2015, PAGEPress Publications

    Dr Marco Gentile

  6. Exercise training improves heart rate recovery in women with breast cancer

    Article • SpringerPlus, August 2015, Springer Science + Business Media

    Dr Marco Gentile

  7. Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 dietary intervention study

    Article • Internal and Emergency Medicine, May 2015, Springer Science + Business Media

    Dr Marco Gentile

  8. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population

    Article • Molecular and Cellular Probes, February 2015, Elsevier

    Dr Marco Gentile

  9. Plasma creatinine levels, estimated glomerular filtration rate and carotid intima media thickness in middle-aged women: A population based cohort study

    Article • Nutrition Metabolism and Cardiovascular Diseases, June 2014, Elsevier

    Dr Marco Gentile

  10. The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Marco Gentile

  11. Association between small dense LDL and early atherosclerosis in a sample of menopausal women

    Article • Clinica Chimica Acta, November 2013, Elsevier

    Dr Marco Gentile

  12. Association of thyroid stimulating hormone levels with subclinical carotid atherosclerosis in a Mediterranean female population

    Article • Cardiovascular Endocrinology, March 2013, Wolters Kluwer Health

    Dr Marco Gentile

  13. Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women

    Article • Menopause The Journal of The North American Menopause Society, October 2012, Wolters Kluwer Health

    Dr Marco Gentile

  14. An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations

    Article • Journal of Lipid Research, August 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Marco Gentile

  15. Familial Dyslipidemias: From Genetics to Clinical Picture

    Article • January 2011, Wiley

    Dr Marco Gentile

  16. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women

    Article • European Journal of Clinical Nutrition, June 2010, Nature

    Dr Marco Gentile

  17. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy

    Article • Atherosclerosis, June 2010, Elsevier

    Dr Marco Gentile

  18. Vascular preventive measures: the progression from asymptomatic to symptomatic atherosclerosis management. Evidence on usefulness of early diagnosis in women and children

    Article • Future Cardiology, March 2010, Future Medicine

    Dr Marco Gentile

  19. Efficacy and safety of rosuvastatin in the management of dyslipidemia

    Article • Vascular Health and Risk Management, April 2009, Taylor & Francis

    Dr Marco Gentile

  20. Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events

    Article • Atherosclerosis, March 2009, Elsevier

    Dr Marco Gentile

  21. Inhibition of Secretory Phospholipase A2-Induced Cytokine Production in Human Lung Macrophages by Budesonide

    Article • International Archives of Allergy and Immunology, January 2009, Karger Publishers

    Dr Marco Gentile

  22. Menstrual cycle length, serum lipids and lipoproteins in a cohort of Italian Mediterranean women: Findings from Progetto ATENA

    Article • Nutrition Metabolism and Cardiovascular Diseases, December 2008, Elsevier

    Dr Marco Gentile

  23. Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome

    Article • Metabolism, April 2008, Elsevier

    Dr Marco Gentile

  24. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena

    Article • Clinica Chimica Acta, February 2008, Elsevier

    Dr Marco Gentile

  25. Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia

    Article • Heart, January 2007, BMJ

    Dr Marco Gentile

  26. The Mediterranean Diet in Italy: An Update

    Article • January 2006, Karger Publishers

    Dr Marco Gentile

  27. Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors

    Article • Metabolism, November 2003, Elsevier

    Dr Marco Gentile

  28. Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes

    Article • European Journal of Immunology, January 2002, Wiley

    Dr Marco Gentile

  29. Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors

    Article • The Journal of Immunology, March 2001, The American Association of Immunologists

    Dr Marco Gentile

  30. Histamine-Induced Activation of Human Lung Macrophages

    Article • International Archives of Allergy and Immunology, January 2001, Karger Publishers

    Dr Marco Gentile

  31. Secretory Phospholipases A2 Induce  -Glucuronidase Release and IL-6 Production from Human Lung Macrophages

    Article • The Journal of Immunology, May 2000, The American Association of Immunologists

    Dr Marco Gentile

  32. Antihistaminic and Anti-inflammatory Effects of Mizolastine

    Article • January 2000, Elsevier

    Dr Marco Gentile

  33. Lipid Mediators from Mast Cells and Basophils in Allergic Diseases

    Article • January 2000, Elsevier

    Dr Marco Gentile

  34. Metabolism of Lipid Mediators in Human Eosinophils

    Article • January 2000, Karger Publishers

    Dr Marco Gentile

  35. Are the anti-allergic properties of H1-antihistamines of any clinical relevance?

    Article • Revue Française d Allergologie et d Immunologie Clinique, January 2000, Elsevier

    Dr Marco Gentile

  36. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-l-carnitine

    Article • Biochemical Pharmacology, October 1999, Elsevier

    Dr Marco Gentile

  37. Secretory Phospholipase A2: A Putative Mediator of Airway Inflammation

    Article • International Archives of Allergy and Immunology, January 1999, Karger Publishers

    Dr Marco Gentile

  38. In situ characterization of mast cells in the frog Rana esculenta

    Article • Cell and Tissue Research, March 1998, Springer Science + Business Media

    Dr Marco Gentile